Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study

Current antiretroviral (ARV) therapy for the treatment of human immunodeficiency virus (HIV-1)-infected patients provides long-term control of viral load (VL). Darunavir (DRV) is a nonpeptidomimetic protease inhibitor approved for use with a ritonavir booster (DRV/r). This study evaluated the effect...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Antinori, Andrea, Meraviglia, Paola, Monforte, Antonella d’Arminio, Castagna, Antonella, Mussini, Cristina, Bini, Teresa, Gianotti, Nicola, Rusconi, Stefano, Colella, Elisa, Airoldi, Giuseppe, Mancusi, Daniela, Termini, Roberta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Clinical Trial Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4866750/
https://ncbi.nlm.nih.gov/pubmed/27226708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S104875
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi